Search For "dcgi"
CSIR hopeful to get permission today from DCGI to test herb on humans for
Updated : 5 years, 10 months ago IST
New Delhi [India], May 7 (ANI): The Council for Scientific and Industrial Research (CSIR) is exploring a native herb as a biological medicine or "phytopharmaceutical ", which is already being tested as medicine for dengue, for its efficacy to combat COVID-19.
Read More
COVID-19 crisis: Health ministry asks Indian Pharma Trade channels to ensu
Updated : 5 years, 10 months ago IST
New Delhi [India], May 6 (ANI): The Union Health Ministry has directed Indian Pharma Trade channels to ensure the availability of 55 drugs for ICU management and another 96 drugs for general availability and treatment of various co-morbid conditions during the COVID-19 crisis.
Read More
Too early for comparisons between Hydroxychloroquine and Remdesivir in COV
Updated : 5 years, 10 months ago IST
New Delhi [India], May 5 (ANI): It is too early to say whether Hydroxychloroquine or Remdesivir works better against COVID-19, as it can be ascertained only after conducting trials, according to the Director-General (DG) of Council of Scientific and Industrial Research (CSIR), Dr Shekhar C M
Read More
Zydus Cadila approaches DCGI to use hepatitis drug for COVID-19 clinical t
Updated : 5 years, 10 months ago IST
New Delhi [India], May 5 (ANI): The country's top drug regulator, Drug Controller General of India (DCGI), has received an application from Zydus Cadila, the leading global pharmaceutical company in India, to conduct clinical trial using antiviral drug 'Pegylated Interferon Alpha-2b' in adul
Read More
Glenmark to conduct clinical trials on Favipiravir anti-viral tablets for
Updated : 5 years, 10 months ago IST
Mumbai (Maharashtra) [India], April 30 (ANI): Glenmark Pharmaceuticals said on Thursday it has received approval from the Drug Controller General of India (DCGI) to conduct clinical trials on Favipiravir anti-viral tablets on COVID-19 patients.
Read More
DCGI permits import of drug with residual shelf life less than 60 pc
Updated : 5 years, 10 months ago IST
New Delhi [India], April 18 (ANI): In view of the COVID-19 pandemic, the country's top drug controller has granted permission for the import of drugs with residual shelf life less than 60 per cent under special conditions. This will be effective for a period of three months or till further o
Read More
Top drug regulator to ensure no shortage of essential, critical drugs amid
Updated : 5 years, 11 months ago IST
New Delhi [India], April 18 (ANI): Warning against stockpiling of medicines and creating supply chain shortages, the Union health ministry has directed the country's top drug regulator to ensure there is no shortage of essential and critical drugs pertaining to COVID-19 disease and to ensure
Read More
Drug regulator asks states to give clearance to industrial oxygen manufact
Updated : 5 years, 11 months ago IST
New Delhi [India], April 7 (ANI): In a step to ensure adequate supply of `oxygen for medical use' for treating coronavirus patients, the country's top drug regulator has asked drug regulators in all states and UTs to give requisite approvals within 24 hours to the manufacturers of industrial
Read More
DGCI gives test license to 18 companies to conduct COVID-19 tests
Updated : 5 years, 11 months ago IST
New Delhi [India], Mar 20 (ANI): The Drug Controller General of India (DCGI) has given test licence to 18 companies including international and private companies to conduct coronavirus (COVID-19) tests in India.
Read More
Zydus announces world's first drug for treatment of NASH
Updated : 6 years ago IST
Ahmedabad (Gujarat) [India], Mar 5 (ANI): Global pharmaceutical company Zydus Cadila, on Thursday announced that the Drug Controller General of India (DCGI) has approved its new drug application (NDA) for Saroglitazar, a medicine for the treatment of a liver disease called Non-Cirrhotic Non-
Read More